Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 13 11 2022
accepted: 14 02 2023
medline: 28 3 2023
entrez: 27 3 2023
pubmed: 28 3 2023
Statut: epublish

Résumé

Extracellular vesicles include exosomes, microvesicles, and apoptotic bodies. Their cargos contain a diverse variety of lipids, proteins, and nucleic acids that are involved in both normal physiology and pathology of the ocular system. Thus, studying extracellular vesicles may lead to a more comprehensive understanding of the pathogenesis, diagnosis, and even potential treatments for various diseases. The roles of extracellular vesicles in inflammatory eye disorders have been widely investigated in recent years. The term "inflammatory eye diseases" refers to a variety of eye conditions such as inflammation-related diseases, degenerative conditions with remarkable inflammatory components, neuropathy, and tumors. This study presents an overview of extracellular vesicles' and exosomes' pathogenic, diagnostic, and therapeutic values in inflammatory eye diseases, as well as existing and potential challenges.

Identifiants

pubmed: 36969177
doi: 10.3389/fimmu.2023.1097456
pmc: PMC10033955
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1097456

Informations de copyright

Copyright © 2023 Habibi, Zarei-Behjani, Falamarzi, Malekpour, Ebrahimi, Soleimani, Nejabat, Khosravi, Moayedfard, Pakbaz, Dehdari Ebrahimi and Azarpira.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Exp Eye Res. 2019 Dec;189:107813
pubmed: 31560926
Front Immunol. 2016 Feb 08;7:37
pubmed: 26904026
Arthritis Res Ther. 2017 Jan 25;19(1):14
pubmed: 28122643
Curr Opin Rheumatol. 2009 Sep;21(5):465-70
pubmed: 19568172
Cancer Lett. 2018 Sep 1;431:11-21
pubmed: 29800684
Ophthalmol Ther. 2014 Dec;3(1-2):17-36
pubmed: 25134495
Int J Mol Sci. 2020 Sep 25;21(19):
pubmed: 32992741
Br J Pharmacol. 2019 Jul;176(13):2179-2194
pubmed: 30883703
Neural Regen Res. 2023 Mar;18(3):513-518
pubmed: 36018156
Eye (Lond). 2006 Oct;20(10):1196-206
pubmed: 17019419
Chin Med J (Engl). 2018 Mar 20;131(6):704-712
pubmed: 29521294
Cell Rep Med. 2023 Jan 17;4(1):100881
pubmed: 36603578
J Autoimmun. 2016 May;69:102-6
pubmed: 26994904
Proteomes. 2019 May 13;7(2):
pubmed: 31086060
Curr Mol Med. 2021;21(8):675-689
pubmed: 32682377
Stem Cell Res Ther. 2022 May 3;13(1):174
pubmed: 35505403
Stem Cells Transl Med. 2019 Nov;8(11):1192-1201
pubmed: 31290598
Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347
pubmed: 32113513
Biomaterials. 2014 Nov;35(34):9302-10
pubmed: 25132601
PLoS One. 2014 Apr 28;9(4):e95665
pubmed: 24777200
Indian J Pediatr. 2017 Dec;84(12):937-944
pubmed: 28620731
Annu Rev Med. 2017 Jan 14;68:331-343
pubmed: 28099084
Arch Ophthalmol. 2010 Aug;128(8):1059-64
pubmed: 20697009
J Clin Exp Dent. 2017 Apr 1;9(4):e584-e589
pubmed: 28469828
Hum Cell. 2022 May;35(3):771-778
pubmed: 35258808
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Glia. 2020 Dec;68(12):2705-2724
pubmed: 32645245
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):702-714
pubmed: 29392316
Eye Brain. 2015 Sep 28;7:59-81
pubmed: 28539795
Arch Ophthalmol. 2005 Dec;123(12):1639-43
pubmed: 16344433
Exp Eye Res. 2015 Mar;132:73-7
pubmed: 25619138
Dtsch Arztebl Int. 2010 Feb;107(5):75-83; quiz 84
pubmed: 20186318
Can Respir J. 2022 Dec 20;2022:1485719
pubmed: 36582191
Dtsch Arztebl Int. 2017 May 26;114(20):354-361
pubmed: 28610655
Expert Opin Biol Ther. 2018 Dec;18(12):1257-1270
pubmed: 30408422
Clin Epidemiol. 2014 Jul 30;6:247-55
pubmed: 25114590
Front Cell Dev Biol. 2021 Apr 01;9:643680
pubmed: 33869195
Curr Eye Res. 2019 Jan;44(1):67-75
pubmed: 30198786
Clin Exp Ophthalmol. 2012 May-Jun;40(4):341-9
pubmed: 22356435
J Immunol. 2019 Mar 15;202(6):1693-1703
pubmed: 30760623
Prog Retin Eye Res. 2020 Nov;79:100849
pubmed: 32169632
J Chem Neuroanat. 2019 Mar;96:134-139
pubmed: 30639447
Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2610-2622
pubmed: 29684588
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5473-5480
pubmed: 30452601
Clin Immunol Immunopathol. 1994 Aug;72(2):162-5
pubmed: 8050187
Cancer Lett. 2016 Sep 28;380(1):47-58
pubmed: 27317650
Anat Rec (Hoboken). 2020 Jun;303(6):1727-1734
pubmed: 31136100
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Arch Ophthalmol. 2001 May;119(5):670-6
pubmed: 11346394
Biochem Biophys Rep. 2020 May 11;22:100760
pubmed: 32420462
Scand J Rheumatol. 2006 Sep-Oct;35(5):379-83
pubmed: 17062438
Front Genet. 2022 Mar 29;13:847679
pubmed: 35422841
J Biol Chem. 2005 Aug 12;280(32):28917-26
pubmed: 15944158
Biochem Biophys Res Commun. 2019 Mar 19;510(4):565-572
pubmed: 30739785
Stem Cells Transl Med. 2017 Apr;6(4):1273-1285
pubmed: 28198592
Pediatr Clin North Am. 2015 Feb;62(1):201-23
pubmed: 25435120
Arch Ophthalmol. 2002 Sep;120(9):1232-3
pubmed: 12215105
Cornea. 1994 May;13(3):202-9
pubmed: 8033568
Invest Ophthalmol Vis Sci. 2015 May;56(5):2993-3003
pubmed: 26024085
Lancet Neurol. 2023 Jan;22(1):89-100
pubmed: 36155661
Front Immunol. 2020 May 29;11:1051
pubmed: 32547555
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):294-303
pubmed: 30657854
Ther Adv Chronic Dis. 2014 Jan;5(1):30-43
pubmed: 24381726
Dev Neurobiol. 2019 Aug;79(8):819-836
pubmed: 31297983
Mol Cell Proteomics. 2010 Jun;9(6):1085-99
pubmed: 20124223
J Cell Biochem. 2020 Apr 10;:
pubmed: 32277521
Leukemia. 2014 Apr;28(4):970-3
pubmed: 24445866
Oncol Rep. 2020 Feb;43(2):635-645
pubmed: 31922233
PLoS One. 2017 Feb 27;12(2):e0171153
pubmed: 28241021
Eye (Lond). 2007 Jun;21(6):752-9
pubmed: 16575415
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2470-2477
pubmed: 29847652
Oral Dis. 2010 Jan;16(1):34-8
pubmed: 19627513
Adv Drug Deliv Rev. 2020;159:308-321
pubmed: 32151658
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5323-9
pubmed: 25015352
Transl Vis Sci Technol. 2020 Nov 02;9(12):1
pubmed: 33200043
Front Pharmacol. 2018 Oct 29;9:1199
pubmed: 30420804
Stem Cell Res Ther. 2021 Aug 26;12(1):478
pubmed: 34446113
Exp Eye Res. 2015 Feb;131:29-41
pubmed: 25533679
Int J Mol Sci. 2018 Jun 20;19(6):
pubmed: 29925789
Int J Ophthalmol. 2018 Apr 18;11(4):559-566
pubmed: 29675371
Prog Retin Eye Res. 2017 Jul;59:158-177
pubmed: 28465248
Sci Rep. 2017 Jun 28;7(1):4323
pubmed: 28659587
Immunol Rev. 2006 Oct;213:23-35
pubmed: 16972894
PLoS One. 2020 Aug 25;15(8):e0237995
pubmed: 32841267
BMC Cancer. 2014 Dec 16;14:962
pubmed: 25510783
JAMA. 2010 Jul 28;304(4):452-60
pubmed: 20664046
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4101-7
pubmed: 27537259
Stem Cell Reports. 2017 May 9;8(5):1214-1225
pubmed: 28494937
N Engl J Med. 2017 Mar 16;376(11):1047-1053
pubmed: 28296617
Anal Cell Pathol (Amst). 2021 Jul 22;2021:9983900
pubmed: 34336556
J Cell Mol Med. 2018 Nov;22(11):5244-5256
pubmed: 30133118
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Immune Netw. 2022 Oct 07;22(6):e49
pubmed: 36627935
Arch Intern Med. 2004 Jun 28;164(12):1275-84
pubmed: 15226160
Indian J Ophthalmol. 2015 Feb;63(2):93-102
pubmed: 25827538
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5194-5200
pubmed: 30372747
Biomaterials. 2019 Mar;197:146-160
pubmed: 30654160
Am J Optom Physiol Opt. 1977 Jan;54(1):49-51
pubmed: 860751
Transl Vis Sci Technol. 2021 Feb 5;10(2):12
pubmed: 34003896
Korean J Neurotrauma. 2018 Oct;14(2):55-60
pubmed: 30402419
Am J Pathol. 2018 Mar;188(3):559-573
pubmed: 29429545
Sci Rep. 2017 Feb 06;7:40548
pubmed: 28165027
Pharmacol Res. 2022 Apr;178:106135
pubmed: 35192956
Front Immunol. 2019 Feb 19;10:232
pubmed: 30837991
Acta Diabetol. 2014 Dec;51(6):1055-64
pubmed: 25374383
Eye Vis (Lond). 2016 Dec 22;3:34
pubmed: 28032115
Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF68-80
pubmed: 24335072
Oncotarget. 2016 Aug 2;7(31):49623-49635
pubmed: 27391064
Life Sci. 2022 Dec 1;310:120938
pubmed: 36150466
Cancers (Basel). 2020 Oct 11;12(10):
pubmed: 33050649
Cancers (Basel). 2020 Jun 12;12(6):
pubmed: 32545553
Int J Ophthalmol. 2020 Sep 18;13(9):1493-1498
pubmed: 32953591
Lancet Glob Health. 2021 Apr;9(4):e418-e430
pubmed: 33607015
Int Immunopharmacol. 2011 Jul;11(7):789-93
pubmed: 21310255
Proteomics. 2015 Jan;15(2-3):260-71
pubmed: 25307053
Br J Community Nurs. 2004 Dec;9(12):545-7
pubmed: 15655491
BMC Ophthalmol. 2018 Jun 8;18(1):139
pubmed: 29884142
J Neurooncol. 2013 May;113(1):1-11
pubmed: 23456661
Tumour Biol. 2022;44(1):129-152
pubmed: 35964221
Circ Res. 2017 Apr 28;120(9):1466-1476
pubmed: 28298297
Front Immunol. 2012 Sep 21;3:296
pubmed: 23049533
Prog Retin Eye Res. 2009 Jan;28(1):34-62
pubmed: 19063989
Horm Metab Res. 2020 Mar;52(3):142-148
pubmed: 32215885
Ann Rheum Dis. 2015 Nov;74(11):1983-9
pubmed: 24938285
Rheumatology (Oxford). 2006 Feb;45(2):187-91
pubmed: 16332955
Expert Opin Investig Drugs. 2011 Jul;20(7):947-59
pubmed: 21534887
Neth J Med. 1992 Apr;40(3-4):105-7
pubmed: 1603198
Curr Opin Rheumatol. 2000 Sep;12(5):391-8
pubmed: 10990175
Nat Rev Immunol. 2009 Apr;9(4):259-70
pubmed: 19282852
J Cell Mol Med. 2018 Oct;22(10):5008-5019
pubmed: 30030883
World J Stem Cells. 2020 Mar 26;12(3):178-187
pubmed: 32266050
PPAR Res. 2008;2008:164273
pubmed: 18509499
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7455-7464
pubmed: 30914462
Sci Rep. 2017 Jan 31;7:41768
pubmed: 28139754
J Biol Chem. 2013 Sep 27;288(39):28058-67
pubmed: 23926109
Exp Cell Res. 2021 Oct 1;407(1):112792
pubmed: 34454924
J Immunol Res. 2018 May 20;2018:1679197
pubmed: 29888291
Med J Aust. 2019 Mar;210(4):180-187
pubmed: 30767238
Vision Res. 2017 Oct;139:7-14
pubmed: 28412095
Lancet. 2005 Jul 23-29;366(9482):321-31
pubmed: 16039337
Stem Cell Res Ther. 2019 Aug 30;10(1):278
pubmed: 31470892
JAMA Ophthalmol. 2015 Nov;133(11):1341-7
pubmed: 26378747
EBioMedicine. 2016 Aug;10:216-26
pubmed: 27381477
Clin Ophthalmol. 2014 Sep 22;8:1891-911
pubmed: 25284976
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Brain Res. 2016 Sep 1;1646:327-333
pubmed: 27208496
Trends Immunol. 2015 Jun;36(6):354-63
pubmed: 25981967
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
Curr Eye Res. 2022 Nov;47(11):1463-1471
pubmed: 35876610
PLoS One. 2009;4(1):e4160
pubmed: 19129916
J Circ Biomark. 2018 Oct 28;7:1849454418807827
pubmed: 30397416
Curr Eye Res. 2021 Mar;46(3):277-283
pubmed: 32865040
Cancer Biol Ther. 2015;16(9):1387-96
pubmed: 25951497
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9
pubmed: 14578381
Front Pharmacol. 2020 Mar 06;11:235
pubmed: 32210819
Curr Med Res Opin. 2011 Jul;27(7):1465-75
pubmed: 21623685
Prog Retin Eye Res. 2012 Jan;31(1):1-27
pubmed: 21946033
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Ann Rheum Dis. 2020 Jan;79(1):3-18
pubmed: 31672775
Eye (Lond). 2013 Feb;27(2):128-36
pubmed: 23154492
J Cell Mol Med. 2018 Mar;22(3):1992-2000
pubmed: 29411534
Sci Rep. 2017 Sep 14;7(1):11518
pubmed: 28912528
Sci Rep. 2017 Mar 31;7:45329
pubmed: 28361998
Int J Ophthalmol. 2022 May 18;15(5):690-700
pubmed: 35601180
Antioxid Redox Signal. 2017 Nov 1;27(13):913-930
pubmed: 28173719
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Life Sci. 2018 Aug 15;207:212-218
pubmed: 29883722
J Diabetes Complications. 2015 Mar;29(2):275-81
pubmed: 25468312
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16082-7
pubmed: 25349431
Med Hypotheses. 2016 Dec;97:98-101
pubmed: 27876140
Clin Chim Acta. 2019 Oct;497:130-136
pubmed: 31361990
Exp Eye Res. 2007 Jan;84(1):209-12
pubmed: 17094967
Autoimmun Rev. 2016 Mar;15(3):258-71
pubmed: 26655327
J Cell Mol Med. 2020 Apr;24(8):4646-4658
pubmed: 32168427
J Extracell Vesicles. 2013 Feb 15;2:
pubmed: 24009890
Arthritis Rheum. 2005 May;52(5):1517-21
pubmed: 15880835
Exp Eye Res. 2021 Aug;209:108626
pubmed: 34087205
Clin Med (Lond). 2022 Mar;22(2):100-103
pubmed: 35304367
J Proteome Res. 2014 Feb 7;13(2):581-95
pubmed: 24400796
Mol Cytogenet. 2012 Jul 02;5(1):27
pubmed: 22559272
J Pers Med. 2022 Sep 10;12(9):
pubmed: 36143269
J Proteome Res. 2007 Jul;6(7):2802-11
pubmed: 17539671
Diabetes. 2018 Aug;67(8):1639-1649
pubmed: 29866771
Front Mol Biosci. 2021 Jan 29;7:619697
pubmed: 33614707
Cell Mol Immunol. 2021 Feb;18(2):440-451
pubmed: 33408339
Exp Eye Res. 2020 Oct;199:108184
pubmed: 32795526
Semin Cell Dev Biol. 2015 Apr;40:72-81
pubmed: 25724562
Adv Clin Exp Med. 2021 Apr;30(4):421-430
pubmed: 33913264
Sci Rep. 2020 Sep 3;10(1):14521
pubmed: 32884023
Int J Mol Sci. 2022 May 25;23(11):
pubmed: 35682600
Arthritis Rheum. 2011 Feb;63(2):535-44
pubmed: 21280008
Front Immunol. 2020 Aug 06;11:1509
pubmed: 32903777
Medicine (Baltimore). 1965 May;44:187-231
pubmed: 14315274
Clin Exp Ophthalmol. 2019 Apr;47(3):396-417
pubmed: 30938012
Oncol Rep. 2021 Jan;45(1):278-290
pubmed: 33416154
N Engl J Med. 2015 Jun 18;372(25):2428-36
pubmed: 26083207
Postgrad Med J. 2017 Dec;93(1106):766-773
pubmed: 28942431
Curr Eye Res. 2017 Oct;42(10):1358-1367
pubmed: 28636406
Exp Eye Res. 2020 Dec;201:108271
pubmed: 33007305
Theranostics. 2021 Mar 4;11(9):4436-4451
pubmed: 33754070
Antioxidants (Basel). 2020 Aug 04;9(8):
pubmed: 32759750
Mucosal Immunol. 2010 Sep;3(5):425-42
pubmed: 20485329
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4889-4895
pubmed: 31752018
JCI Insight. 2020 May 7;5(9):
pubmed: 32376798
Neural Regen Res. 2022 Mar;17(3):516-522
pubmed: 34380881
Nat Commun. 2011;2:282
pubmed: 21505438
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421
Front Physiol. 2018 Jul 13;9:820
pubmed: 30057551
Int J Nanomedicine. 2020 Dec 29;15:10519-10538
pubmed: 33402823
Int J Mol Sci. 2019 Jun 12;20(12):
pubmed: 31212734
Semin Cell Dev Biol. 2015 Apr;40:41-51
pubmed: 25721812
Subcell Biochem. 2021;97:61-88
pubmed: 33779914
J Biomed Biotechnol. 2011;2011:407031
pubmed: 21660135
Nat Rev Cancer. 2014 Jun;14(6):430-9
pubmed: 24827502

Auteurs

Azam Habibi (A)

Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Zeinab Zarei-Behjani (Z)

Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Kimia Falamarzi (K)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Mahdi Malekpour (M)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Ebrahimi (F)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Masood Soleimani (M)

Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

Mahmood Nejabat (M)

Department of Ophthalmology School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Amir Khosravi (A)

Department of Ophthalmology School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Zahra Moayedfard (Z)

Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Sara Pakbaz (S)

Department of Pathology, University of Toronto, Toronto, ON, Canada.

Niloofar Dehdari Ebrahimi (N)

Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Negar Azarpira (N)

Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH